Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E P COHEN

Showing results (81-90 of 123) with videos related to

Pageof 13
Sort By:
International Journal of Cancer|April 6, 2001
Up-regulation of MUC1 in mammary tumors generated in a double-transgenic mouse expressing human MUC1 cDNA, under the control of 1.4-kb 5' MUC1 promoter sequence and the middle T oncogene, expressed from the MMTV promoterR A Graham, J R Morris, E P Cohen, et al.
Radiation Research|July 1, 1996
Angiotensin II receptor antagonists in the prevention of radiation nephropathyJ E Moulder, B L Fish, E P Cohen, et al.
International Journal of Cancer|May 8, 1992
Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigensT S Kim, S J Russell, M K Collins, et al.
ASAIO Transactions|July 1, 1991
Determinants of dialyzer reuseabilityS G Sievers, J L Stack, W F Piering, et al.
Cancer Gene Therapy|May 7, 1998
Immunization with interleukin-2-secreting allogeneic cells transfected with DNA from mouse melanoma cells induces immune responses that prolong the lives of mice with melanomaT Sun, V Carr-Brendel, E F De Zoeten, et al.
Journal of Neurosurgery|February 24, 2001
Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in miceP Deshmukh, R P Glick, T Lichtor, et al.
Journal of the American Society of Nephrology : JASN|February 1, 1994
Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspectiveR H Sterns, J D Cappuccio, S M Silver, et al.
Nephron|August 5, 1998
End-stage renal disease (ESRD)after bone marrow transplantation: poor survival compar ed to other causes of ESRDE P Cohen, W F Piering, C Kabler-Babbitt, et al.
Immunology|August 24, 1999
Expression of B7.1 in a MUC1-expressing mouse mammary epithelial tumour cell line inhibits tumorigenicity but does not induce autoimmunity in MUC1 transgenic miceM Smith, J M Burchell, R Graham, et al.
Journal of Neuro-Oncology|May 1, 1999
Development of a new mouse brain tumor model using implantable micro-cannulasW Griffitt, R P Glick, T Lichtor, et al.
Pageof 13

Showing results (81-90 of 123) with videos related to

Sort By:
Pageof 13
International Journal of Cancer|April 6, 2001
Up-regulation of MUC1 in mammary tumors generated in a double-transgenic mouse expressing human MUC1 cDNA, under the control of 1.4-kb 5' MUC1 promoter sequence and the middle T oncogene, expressed from the MMTV promoterR A Graham, J R Morris, E P Cohen, et al.
Radiation Research|July 1, 1996
Angiotensin II receptor antagonists in the prevention of radiation nephropathyJ E Moulder, B L Fish, E P Cohen, et al.
International Journal of Cancer|May 8, 1992
Immunity to B16 melanoma in mice immunized with IL-2-secreting allogeneic mouse fibroblasts expressing melanoma-associated antigensT S Kim, S J Russell, M K Collins, et al.
ASAIO Transactions|July 1, 1991
Determinants of dialyzer reuseabilityS G Sievers, J L Stack, W F Piering, et al.
Cancer Gene Therapy|May 7, 1998
Immunization with interleukin-2-secreting allogeneic cells transfected with DNA from mouse melanoma cells induces immune responses that prolong the lives of mice with melanomaT Sun, V Carr-Brendel, E F De Zoeten, et al.
Journal of Neurosurgery|February 24, 2001
Immunogene therapy with interleukin-2-secreting fibroblasts for intracerebrally metastasizing breast cancer in miceP Deshmukh, R P Glick, T Lichtor, et al.
Journal of the American Society of Nephrology : JASN|February 1, 1994
Neurologic sequelae after treatment of severe hyponatremia: a multicenter perspectiveR H Sterns, J D Cappuccio, S M Silver, et al.
Nephron|August 5, 1998
End-stage renal disease (ESRD)after bone marrow transplantation: poor survival compar ed to other causes of ESRDE P Cohen, W F Piering, C Kabler-Babbitt, et al.
Immunology|August 24, 1999
Expression of B7.1 in a MUC1-expressing mouse mammary epithelial tumour cell line inhibits tumorigenicity but does not induce autoimmunity in MUC1 transgenic miceM Smith, J M Burchell, R Graham, et al.
Journal of Neuro-Oncology|May 1, 1999
Development of a new mouse brain tumor model using implantable micro-cannulasW Griffitt, R P Glick, T Lichtor, et al.
Pageof 13